Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x100px

Document › Details

New York Times [The Editorial Board]. (2/24/19). "News: It’s Time for Pharmaceutical Companies to Have Their Tobacco Moment".

	Region	United States (USA)
	Organisation	Sanofi S.A. (Euronext: SAN, Nasdaq: SNY)
	Group	Sanofi (Group) [since May 2011]
	Organisation 2	AbbVie Inc. (NYSE: ABBV)
	Group	AbbVie (Group)
	Product	Actimmune®
	Product 2	Humira®
	Person	Brandicourt, Olivier (Sanofi 201508–201908 CEO before CEO of Bayer HealthCare before Pfizer Inc RETIRED 9/19)

Original document
accessed by [iito] on 2019-02-26

Record changed: 2023-06-05

Picture Berlin Partner Voices Tim Huse BIH Digital Health 650x200px

More documents for Sanofi (Group) [since May 2011]

[1] MeiraGTx Holdings plc. (8/12/24). "Press Release: MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi". London & New York, NY....
[2] Sanofi S.A.. (5/13/24). "Press Release: Sanofi Adds over €1 Billion for Biomanufacturing to €2.5 Billion Already Committed in Major Projects in France to Support Health Sovereignty". Paris....
[3] Sartorius AG. (5/13/24). "Press Release: Sartorius Collaborates with Sanofi to Commercialize End-to-end Platform for Downstream process intensification". Göttingen....
[4] Owkin. (3/21/24). "Press Release: Owkin Expands Collaboration with Sanofi Leveraging AI for Drug Positioning in immunology"....
[5] GenSight Biologics S.A.. (12/22/23). "Press Release: GenSight Biologics Appoints Laurence Rodriguez as Chief Executive Officer". Paris....
[6] Sanofi S.A.. (12/11/23). "Press Release: Statement on FTC Challenge to Proposed License Agreement with Maze Therapeutics". Paris....
[7] Aqemia SAS. (12/5/23). "Press Release: Aqemia Announces a Major Multi-year Collaboration of $140 Million with Sanofi". Paris....
[8] Eligo Bioscience S.A.. (12/5/23). "Press Release: Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines". Paris....
[9] MeiraGTx Holdings plc. (10/30/23). "Press Release: MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities". London & New York, NY....
[10] Sanofi S.A.. (10/3/23). "Press Release: Sanofi Announces Agreement for Potential First-in-Class Vaccine against Extraintestinal Pathogenic E. coli". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]